Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice
- PMID: 33639976
- PMCID: PMC7914043
- DOI: 10.1186/s12985-021-01515-1
Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice
Abstract
Background: Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2 and broke out as a global pandemic in late 2019. The acidic pH environment of endosomes is believed to be essential for SARS-CoV-2 to be able to enter cells and begin replication. However, the clinical use of endosomal acidification inhibitors, typically chloroquine, has been controversial with this respect.
Methods: In this study, RT-qPCR method was used to detect the SARS-CoV-2N gene to evaluate viral replication. The CCK-8 assay was also used to evaluate the cytotoxic effect of SARS-CoV-2. In situ hybridization was used to examine the distribution of the SARS-CoV-2 gene in lung tissues. Hematoxylin and eosin staining was also used to evaluate virus-associated pathological changes in lung tissues.
Results: In this study, analysis showed that endosomal acidification inhibitors, including chloroquine, bafilomycin A1 and NH4CL, significantly reduced the viral yields of SARS-CoV-2 in Vero E6, Huh-7 and 293T-ACE2 cells. Chloroquine and bafilomycin A1 also improved the viability and proliferation of Vero E6 cells after SARS-CoV-2 infection. Moreover, in the hACE2 transgenic mice model of SARS-CoV-2 infection, chloroquine and bafilomycin A1 reduced viral replication in lung tissues and alleviated viral pneumonia with reduced inflammatory exudation and infiltration in peribronchiolar and perivascular tissues, as well as improved structures of alveolar septum and pulmonary alveoli.
Conclusions: Our research investigated the antiviral effects of endosomal acidification inhibitors against SARS-CoV-2 in several infection models and provides an experimental basis for further mechanistic studies and drug development.
Keywords: Bafilomycin A1; Chloroquine; Endosomal acidification; SARS-CoV-2.
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.PLoS Pathog. 2021 Jul 12;17(7):e1009706. doi: 10.1371/journal.ppat.1009706. eCollection 2021 Jul. PLoS Pathog. 2021. PMID: 34252168 Free PMC article.
-
Super-Resolution Imaging Reveals the Mechanism of Endosomal Acidification Inhibitors Against SARS-CoV-2 Infection.Chembiochem. 2024 Aug 19;25(16):e202400404. doi: 10.1002/cbic.202400404. Epub 2024 Jul 29. Chembiochem. 2024. PMID: 38877380
-
Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues.J Virol. 2021 Nov 23;95(24):e0153721. doi: 10.1128/JVI.01537-21. Epub 2021 Sep 22. J Virol. 2021. PMID: 34550769 Free PMC article.
-
Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).Mini Rev Med Chem. 2021;21(6):689-703. doi: 10.2174/1389557520666201117111259. Mini Rev Med Chem. 2021. PMID: 33208074 Review.
-
The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.Molecules. 2020 Dec 31;26(1):142. doi: 10.3390/molecules26010142. Molecules. 2020. PMID: 33396184 Free PMC article. Review.
Cited by
-
Maoto, a traditional herbal medicine, for post-exposure prophylaxis for Japanese healthcare workers exposed to COVID-19: A single center study.J Infect Chemother. 2022 Jul;28(7):907-911. doi: 10.1016/j.jiac.2022.03.014. Epub 2022 Mar 21. J Infect Chemother. 2022. PMID: 35361537 Free PMC article.
-
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2.Viruses. 2022 Jun 7;14(6):1232. doi: 10.3390/v14061232. Viruses. 2022. PMID: 35746703 Free PMC article.
-
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.Int J Mol Sci. 2022 Feb 2;23(3):1716. doi: 10.3390/ijms23031716. Int J Mol Sci. 2022. PMID: 35163638 Free PMC article. Review.
-
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics.Virol J. 2021 Jul 23;18(1):154. doi: 10.1186/s12985-021-01624-x. Virol J. 2021. PMID: 34301275 Free PMC article. Review.
-
Insight into the role of clathrin-mediated endocytosis inhibitors in SARS-CoV-2 infection.Rev Med Virol. 2023 Jan;33(1):e2403. doi: 10.1002/rmv.2403. Epub 2022 Nov 7. Rev Med Virol. 2023. PMID: 36345157 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous